Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.16T | 2.10T | 2.18T | 1.90T | 1.90T | 1.48T |
Gross Profit | 677.45B | 603.02B | 584.52B | 563.85B | 563.85B | 434.32B |
EBITDA | 410.49B | 355.47B | 394.28B | 357.37B | 273.10B | 222.85B |
Net Income | 166.06B | 124.69B | 114.19B | 131.30B | 131.30B | 79.34B |
Balance Sheet | ||||||
Total Assets | 3.79T | 3.42T | 3.15T | 3.15T | 3.04T | 2.40T |
Cash, Cash Equivalents and Short-Term Investments | 818.37B | 650.00B | 558.33B | 558.33B | 506.28B | 446.33B |
Total Debt | 681.32B | 685.74B | 752.16B | 752.16B | 679.81B | 521.61B |
Total Liabilities | 1.88T | 1.70T | 1.68T | 1.68T | 1.74T | 1.40T |
Stockholders Equity | 1.89T | 1.71T | 1.46T | 1.46T | 1.30T | 1.00T |
Cash Flow | ||||||
Free Cash Flow | 258.30B | 228.42B | -12.94B | -12.94B | -112.35B | 10.46B |
Operating Cash Flow | 482.66B | 447.01B | 262.77B | 262.77B | 178.99B | 222.81B |
Investing Cash Flow | -224.24B | -216.59B | -234.40B | -234.40B | -281.55B | -231.49B |
Financing Cash Flow | -129.70B | -146.37B | 14.95B | 14.95B | 113.74B | 29.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $126.35B | 40.14 | 31.02% | 0.63% | 40.51% | 49.81% | |
80 Outperform | $24.18B | 21.45 | 9.39% | 0.09% | -0.57% | 27.75% | |
76 Outperform | $20.09B | 13.71 | 31.00% | ― | -6.93% | 537.94% | |
72 Outperform | $60.97B | 41.72 | 11.63% | 1.29% | 4.86% | -56.43% | |
68 Neutral | $17.31B | 22.44 | 7.70% | 0.44% | 0.85% | -10.01% | |
64 Neutral | $47.72B | 106.77 | 4.14% | 2.02% | 9.77% | -26.50% | |
58 Neutral | €2.95B | 11.66 | -8.77% | 2.74% | 5.06% | -52.33% |